Centesis Catheters Market Size, Share, Industry, Forecast and outlook (2024-2031)

Centesis Catheters Market is segmented By Type (Small-bore Centesis Catheters, Large-bore Centesis Catheters), By Procedure (Paracentesis, Thoracentesis, Arthrocentesis, Amniocentesis, Other), By End-User (Hospitals, Ambulatory Surgical Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030 

Centesis Catheters Market Overview

The Centesis Catheters Market report analyzes the global market size, shares, recent trends, competitive intelligence, and future market outlook. Centesis catheters are medical devices used for diagnostic and therapeutic procedures to remove fluid or perform biopsies from body cavities or organs. They enable minimally invasive and precise access during medical interventions. The market is driven by the increasing prevalence of conditions requiring fluid drainage or tissue sampling, the growing demand for minimally invasive procedures, and technological advancements in catheter design. In America, the Centesis Catheters Market is experiencing substantial growth. Key players in the market include Cook Medical LLC, Becton, Dickinson and Company, Cardinal Health, and other prominent players.

 A centesis catheter is a needle catheter used for aspirating and draining small abscesses during procedures such as paracentesis, thoracentesis, arthrocentesis, and amniocentesis.

Centesis catheters market Summary and Scope

For more insights - Download the Sample

Centesis Catheters Market Trends and Dynamics

The factors influencing the global centesis catheters market are the increasing demand for centesis catheters for target diseases.

The increasing demand for centesis catheters for target diseases is expected to drive market growth in the forecast period

The advantages associated with centesis catheters are expected to increase their demand in the market. Because the catheter's low profile, tapered tip, and smooth transitions reduce resistance, resulting in less patient discomfort. Its echo-enhanced needle enables more precise placement. For maximum drainage, four large drainage holes spiral around the catheter. Up to 34% LESS catheter tip penetration force and up to 16% FASTER flow rate Insertion is safe and controlled, with shorter procedure times. For instance, the valved One-Step centesis catheter incorporates a self-sealing valve to reduce the risk of air entering the pleural space.

Moreover, Becton, Dickinson, and Company’s Safe-T-Centesis thoracentesis/paracentesis device help to reduce the risks associated with percutaneous needle drainage. The latex-free device can also help improve patient comfort and procedural flexibility during thoracentesis and paracentesis procedures. Hence, many companies manufacture centesis catheters with several benefits that are expected to drive market growth.

The problems associated with centesis catheters are expected to hamper the market growth

The complexities associated with centesis procedures are one of the factors expected to hamper the market. For instance, thoracentesis is a common procedure performed in inpatient and outpatient settings by many healthcare providers. Although thoracentesis is generally regarded as a low-risk procedure, complications include pneumothorax, bleeding (puncture site bleeding, chest wall hematoma, and hemothorax), and re-expansion pulmonary edema (REPE) can result in increased morbidity, mortality, and healthcare costs. Although ultrasound and an emphasis on operator expertise have significantly reduced complication rates, pneumothorax remains the most common complication of thoracentesis. REPE is another uncommon complication of thoracentesis. Avoiding excessively negative pleural pressures, either through direct measurement or by paying attention to patient symptoms, may lower the risk of REPE.

COVID-19 Impact on Centesis Catheters Market Growth

To care for the infected population, the demand for medical supplies increases. Respiratory support devices, including an atomizer, a life-support machine, an oxygen generator, and a monitor, are among the most commonly used medical devices in primary care. Furthermore, COVID-19 has increased the demand for medical supplies such as personal protective equipment. As the global number of COVID-19 cases rises, so does the demand for medical supplies among healthcare professionals and the general public for precautionary measures. Manufacturers are concentrating on the opportunity to capitalize on the increased demand for medical supplies to ensure an adequate and consistent supply of personal protective equipment in the workplace. Considering these factors, covid-19 is expected to impact the global centesis catheters market.

Centesis Catheters Market Segment and Shares

Based on procedure Paracentesis segment is expected to dominate the global centesis catheters market

Paracentesis is a procedure that involves inserting a needle or catheter into the peritoneal cavity to collect ascitic fluid for diagnostic or therapeutic purposes. Ascitic fluid can be used to help determine the cause of ascites, as well as to check for infection or the presence of cancer. Paracentesis is a procedure used to obtain a small ascitic fluid sample or drain it for diagnostic or therapeutic purposes. A needle or catheter is inserted into the peritoneal cavity for diagnostic or therapeutic purposes, and ascitic fluid is removed. The needle is inserted at a 45-degree angle or using a z-tracking technique to reduce the risk of developing an ascites fluid leak. There are prepackaged paracentesis kits available, including plastic sheath cannulas attached to a syringe and a stopcock. Traditional large-bore intravenous (IV) catheters and 18-gauge to 20-gauge standard or spinal needles can also be used. These can be connected to a syringe for aspiration and IV tubing for fluid drainage. Hence, with the increase in paracentesis procedures, the demand for centesis catheters is also expected to grow.

Centesis Catheters Market Geographical Analysis

North America region is expected to hold the largest market share in the global centesis catheters market

This region is expected to dominate the market due to the high volume of cardiovascular, neurovascular, and other target procedures. The presence of a well-established healthcare system and increasing investments by hospitals to upgrade their medical supplies are driving the growth of this regional market. For instance, with over 200,000 procedures performed each year in the United States, bypass surgery is the most common type of heart surgery.

The presence of major key players is expected to drive market growth in this region. For instance, Merit Medical Systems, Inc. in the United States is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company’s One-Step centesis catheter has a low profile, tapered tip, and smooth transitions to reduce resistance and discomfort in the patient. Its echo-enhanced needle allows for more precise placement, and the four large drainage holes spiral around the catheter to provide maximum drainage.

Centesis Catheters Companies and Competitive Landscape

With mergers, acquisitions, and product launches, the global centesis catheters market is moderately competitive. Some of the key players in the market are Argon Medical, AngioDynamics, Becton, Dickinson and Company, Blue Neem Medical Devices, Boston Scientific Corporation, Cardinal Health, KM Medical, Mermaid Medical A/S, Cook Medical, Galt Medical Corp.

Galt Medical Corp

Overview: Galt Medical Corp. is a leading provider of vascular and interventional medical devices, developing and manufacturing various products for interventional procedures. Through a network of distributors, they provide privately labeled products to medical device OEMs, and Galt-branded products to clinicians worldwide. Clinicians use Galt products on six continents for a variety of Interventional Radiology, Interventional Cardiology Vascular Surgery, and IV Therapy procedures. The company was founded in 1991.

Product Portfolio: The Galt Medical Corp. OTN system is designed to improve ease in every centesis procedure, with three large, skived holes, a smooth transition, and a secure slip-fit needle design.

Key Developments: On 20th May 2019, Galt Medical Corp acquired Arrotek Medical Limited, expanding the former's portfolio of minimally invasive devices.